BioSpace News Archive

Expanded FluoroType™ MTBDR 2.0 Liquid Array molecular assay with CE-IVD mark provides highly differentiated tuberculosis (TB) detection and antibiotic resistance testing

AgeX Therapeutics, Inc., a biotechnology company focused on innovative therapeutics for human aging, announced that it has received $4.5 million from the exercise of AgeX common stock warrants.

Award-winning provider of non-medical home care ranked No. 100 on Entrepreneur list

PAM Rehabilitation Hospital of Tulsa, which is part of the Post Acute Medical network of hospitals, will expand patient access to inpatient medical rehabilitation care with the addition of 13 beds.

INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer

Titan Medical Inc. announces that management will webcast a conference call on Thursday, March 28 at 4:30 p.m. ET to provide a business update on the Company and its SPORT Surgical System.

Three founding partners, Digital Surgery Ltd., Verb Surgical and Taylor Wessing LLP, host the first-ever FT Digital Surgery Summit, where a high-level cross-section of stakeholders converged to adopt a digital vision for the future of surgery.

FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, announces an exclusive video interview with Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. live on Wall Street.

Wagner Reese has welcomed Attorney Jeff Gibson as a new Partner of the firm. He focuses his practice on defective drug and medical device cases, product liability litigation, and sexual abuse claims. [22-March-2019] INDIANAPOLIS , March 22, 2019 /PRNewswire/ -- Attorney Jeff Gibson has joined Wagner Reese as a new Partner. T

Neuronix Ltd. announced that the U.S. Food and Drug Administration Neurological Devices Advisory Committee met on March 21 to consider data and receive public comment about the neuroAD™ Therapy System, a non-invasive medical device for the treatment of mild-to-moderate Alzheimer’s disease.